Company Monitoring Page for Biomarin

latest headlines for company on cafepharma

Amicus' 'Transformative' Changes Look More Like Big Step Backward
TheStreet.com
Thu, 11/21/13 - 12:07 pm
Tags:
Amicus Therapeutics, GSK, Sanofi, Biomarin, Callidus Biopharma, Amigal
BioMarin Seen Luring $13 Billion Takeover Bid: Real M&A
Bloomberg
Thu, 11/21/13 - 11:00 am
Tags:
Biomarin, M&A
4 Biotech Stocks Spiking on Unusual Volume
TheStreet.com
Thu, 11/21/13 - 08:23 am
Tags:
Biomarin, Onconova, ANI Pharmaceuticals, Clovis Oncology
FDA panel backs approval of BioMarin's Morquio A Syndrome drug
Yahoo/Reuters
Tue, 11/19/13 - 04:18 pm
Tags:
FDA, advisory panels, Biomarin, Morquio A Syndrome, Vimizim
Keep an Eye on BioMarin, Amgen, Merck, and AstraZeneca Today
Motley Fool
Tue, 11/19/13 - 12:24 pm
Tags:
Biomarin, Amgen, Merck, AstraZeneca
BioMarin shares rally as FDA mutes criticism of rare disorder drug
MarketWatch
Sat, 11/16/13 - 01:18 pm
Tags:
Biomarin, Morquio A Syndrome, Vimizim
BioMarin's Morquio A drug confers "modest" benefit -FDA review
Yahoo/Reuters
Fri, 11/15/13 - 09:04 am
Tags:
Biomarin, Morquio A Syndrome, FDA, Vimizim
BioMarin Pharma Q3 Net Loss Deepens, Revenue Rises
Motley Fool
Fri, 10/25/13 - 09:58 am
Tags:
earnings, Biomarin
3 Orphan Drugmakers to Watch
Motley Fool
Wed, 10/23/13 - 08:43 am
Tags:
orphan drugs, Biomarin, GSK, Vimizim, Tafinlar, Mekinist, Myozyme, Cerazyme, Sanofi
Catalyst Pharmaceuticals And Their Business Plan
Seeking Alpha
Mon, 10/21/13 - 11:51 am
Tags:
Catalyst Pharmaceutical Partners, Biomarin, Biogen Idec, Firdapse, Lambert-Eaton myasthenic syndrome
Five Data Presentations on BioMarin's BMN 673 PARP Inhibitor at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Yahoo/Globe Newswire
Sun, 10/20/13 - 02:29 pm
Tags:
Biomarin, BMN 673, solid tumors
Top Biotechs Set to Win in the War on Cancer
Yahoo/Wall St 24-7
Thu, 10/3/13 - 11:57 am
Tags:
biotech, Biomarin, Immunogen, Ariad Pharmaceuticals, Amgen, Celgene, Gilead Sciences
BioMarin Provides Updated Phase 1/2 Data on BMN 673 in Breast Cancer at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:33 pm
Tags:
BMN 673, breast cancer, Biomarin
BioMarin doses first patient in Phase 1/2 trial with BMN 190
Yahoo/Fly on the Wall
Mon, 09/23/13 - 10:48 am
Tags:
Biomarin, BMN-190, Batten disease
BioMarin's Buyout False Start Leads Biotech's Record Surge
Motley Fool
Sun, 09/22/13 - 11:32 am
Tags:
Biomarin, Roche
Roche CEO Says Drugmaker Isn’t Seeking Financing for Deal
Bloomberg
Fri, 09/20/13 - 09:53 am
Tags:
Roche, Pharma CEOs, Severin Schwan, M&A, Biomarin
5 Things You Need to Know From BioMarin's R&D Day
Motley Fool
Thu, 09/19/13 - 03:09 am
Tags:
R&D, Biomarin, Vimizim, BMN-701, BMN-111, BMN-673
Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
Tags:
biotech, M&A, ONYX Pharmaceuticals, Alexion, Biomarin, Incyte, Medivation, Pharmacyclics, Regeneron, Seattle Genetics
3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
Tags:
FDA, diabetes, Forixga, Bristol-Myers Squibb, AstraZeneca, Biomarin, Vimizim, Amylin, metreleptin
Tiny Catalyst soars after rare disease drug scores 'breakthrough' at FDA
Fierce Biotech
Tue, 08/27/13 - 11:01 am
Tags:
Catalyst Pharmaceutical Partners, Firdapse, Biomarin, FDA, breakthrough therapies, Lambert-Eaton myasthenic syndrome

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.